腫瘍臨床試験の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2608)
◆英語タイトル:Global Oncology Clinical Trial Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2608
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:105
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、腫瘍臨床試験の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(前立腺がん、肺がん、乳がん、白血病、その他)、用途別市場規模(病院、クリニック、外来手術センター)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・腫瘍臨床試験の市場動向
・企業の競争状況、市場シェア
・腫瘍臨床試験の種類別市場規模(前立腺がん、肺がん、乳がん、白血病、その他)
・腫瘍臨床試験の用途別市場規模(病院、クリニック、外来手術センター)
・腫瘍臨床試験の北米市場規模2016-2027(アメリカ、カナダ)
・腫瘍臨床試験の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・腫瘍臨床試験のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・腫瘍臨床試験の中南米市場規模2016-2027(メキシコ、ブラジル)
・腫瘍臨床試験の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(IQVIA、Charles River Laboratory、ICON Plc、Medelis, Inc.、Medpace Holdings, Inc.、PAREXEL International、Pharmaceutical Product Development, LLC、Pivotal、PRA Health Sciences、Syneos Health)
・結論
【レポートの概要】

Clinical trials are the final step in a long process that begins with research in a lab.
Oncology trials are predominantly early-phase studies that evaluate surrogate end points and are small, single arm, and open label.

Market Analysis and Insights: Global Oncology Clinical Trial Market
The global Oncology Clinical Trial market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Clinical Trial market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Clinical Trial market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Clinical Trial market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Clinical Trial market.

Global Oncology Clinical Trial Scope and Market Size
Oncology Clinical Trial market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Clinical Trial market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prostate Cancer
Lung Cancer
Breast Cancer
Leukemia
Others

Segment by Application
Hospital
Clinic
Lab

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
IQVIA
Charles River Laboratory
ICON Plc
Medelis, Inc.
Medpace Holdings, Inc.
PAREXEL International
Pharmaceutical Product Development, LLC
Pivotal
PRA Health Sciences
Syneos Health

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Clinical Trial Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prostate Cancer
1.2.3 Lung Cancer
1.2.4 Breast Cancer
1.2.5 Leukemia
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Clinical Trial Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Lab
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oncology Clinical Trial Market Perspective (2016-2027)
2.2 Oncology Clinical Trial Growth Trends by Regions
2.2.1 Oncology Clinical Trial Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncology Clinical Trial Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Clinical Trial Forecasted Market Size by Regions (2022-2027)
2.3 Oncology Clinical Trial Industry Dynamic
2.3.1 Oncology Clinical Trial Market Trends
2.3.2 Oncology Clinical Trial Market Drivers
2.3.3 Oncology Clinical Trial Market Challenges
2.3.4 Oncology Clinical Trial Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oncology Clinical Trial Players by Revenue
3.1.1 Global Top Oncology Clinical Trial Players by Revenue (2016-2021)
3.1.2 Global Oncology Clinical Trial Revenue Market Share by Players (2016-2021)
3.2 Global Oncology Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Clinical Trial Revenue
3.4 Global Oncology Clinical Trial Market Concentration Ratio
3.4.1 Global Oncology Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Clinical Trial Revenue in 2020
3.5 Oncology Clinical Trial Key Players Head office and Area Served
3.6 Key Players Oncology Clinical Trial Product Solution and Service
3.7 Date of Enter into Oncology Clinical Trial Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Clinical Trial Breakdown Data by Type
4.1 Global Oncology Clinical Trial Historic Market Size by Type (2016-2021)
4.2 Global Oncology Clinical Trial Forecasted Market Size by Type (2022-2027)

5 Oncology Clinical Trial Breakdown Data by Application
5.1 Global Oncology Clinical Trial Historic Market Size by Application (2016-2021)
5.2 Global Oncology Clinical Trial Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Oncology Clinical Trial Market Size (2016-2027)
6.2 North America Oncology Clinical Trial Market Size by Type
6.2.1 North America Oncology Clinical Trial Market Size by Type (2016-2021)
6.2.2 North America Oncology Clinical Trial Market Size by Type (2022-2027)
6.2.3 North America Oncology Clinical Trial Market Size by Type (2016-2027)
6.3 North America Oncology Clinical Trial Market Size by Application
6.3.1 North America Oncology Clinical Trial Market Size by Application (2016-2021)
6.3.2 North America Oncology Clinical Trial Market Size by Application (2022-2027)
6.3.3 North America Oncology Clinical Trial Market Size by Application (2016-2027)
6.4 North America Oncology Clinical Trial Market Size by Country
6.4.1 North America Oncology Clinical Trial Market Size by Country (2016-2021)
6.4.2 North America Oncology Clinical Trial Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Oncology Clinical Trial Market Size (2016-2027)
7.2 Europe Oncology Clinical Trial Market Size by Type
7.2.1 Europe Oncology Clinical Trial Market Size by Type (2016-2021)
7.2.2 Europe Oncology Clinical Trial Market Size by Type (2022-2027)
7.2.3 Europe Oncology Clinical Trial Market Size by Type (2016-2027)
7.3 Europe Oncology Clinical Trial Market Size by Application
7.3.1 Europe Oncology Clinical Trial Market Size by Application (2016-2021)
7.3.2 Europe Oncology Clinical Trial Market Size by Application (2022-2027)
7.3.3 Europe Oncology Clinical Trial Market Size by Application (2016-2027)
7.4 Europe Oncology Clinical Trial Market Size by Country
7.4.1 Europe Oncology Clinical Trial Market Size by Country (2016-2021)
7.4.2 Europe Oncology Clinical Trial Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oncology Clinical Trial Market Size (2016-2027)
8.2 Asia-Pacific Oncology Clinical Trial Market Size by Type
8.2.1 Asia-Pacific Oncology Clinical Trial Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncology Clinical Trial Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncology Clinical Trial Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncology Clinical Trial Market Size by Application
8.3.1 Asia-Pacific Oncology Clinical Trial Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncology Clinical Trial Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncology Clinical Trial Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncology Clinical Trial Market Size by Region
8.4.1 Asia-Pacific Oncology Clinical Trial Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncology Clinical Trial Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oncology Clinical Trial Market Size (2016-2027)
9.2 Latin America Oncology Clinical Trial Market Size by Type
9.2.1 Latin America Oncology Clinical Trial Market Size by Type (2016-2021)
9.2.2 Latin America Oncology Clinical Trial Market Size by Type (2022-2027)
9.2.3 Latin America Oncology Clinical Trial Market Size by Type (2016-2027)
9.3 Latin America Oncology Clinical Trial Market Size by Application
9.3.1 Latin America Oncology Clinical Trial Market Size by Application (2016-2021)
9.3.2 Latin America Oncology Clinical Trial Market Size by Application (2022-2027)
9.3.3 Latin America Oncology Clinical Trial Market Size by Application (2016-2027)
9.4 Latin America Oncology Clinical Trial Market Size by Country
9.4.1 Latin America Oncology Clinical Trial Market Size by Country (2016-2021)
9.4.2 Latin America Oncology Clinical Trial Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oncology Clinical Trial Market Size (2016-2027)
10.2 Middle East & Africa Oncology Clinical Trial Market Size by Type
10.2.1 Middle East & Africa Oncology Clinical Trial Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncology Clinical Trial Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncology Clinical Trial Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncology Clinical Trial Market Size by Application
10.3.1 Middle East & Africa Oncology Clinical Trial Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncology Clinical Trial Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncology Clinical Trial Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncology Clinical Trial Market Size by Country
10.4.1 Middle East & Africa Oncology Clinical Trial Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncology Clinical Trial Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Oncology Clinical Trial Introduction
11.1.4 IQVIA Revenue in Oncology Clinical Trial Business (2016-2021)
11.1.5 IQVIA Recent Development
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Details
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Oncology Clinical Trial Introduction
11.2.4 Charles River Laboratory Revenue in Oncology Clinical Trial Business (2016-2021)
11.2.5 Charles River Laboratory Recent Development
11.3 ICON Plc
11.3.1 ICON Plc Company Details
11.3.2 ICON Plc Business Overview
11.3.3 ICON Plc Oncology Clinical Trial Introduction
11.3.4 ICON Plc Revenue in Oncology Clinical Trial Business (2016-2021)
11.3.5 ICON Plc Recent Development
11.4 Medelis, Inc.
11.4.1 Medelis, Inc. Company Details
11.4.2 Medelis, Inc. Business Overview
11.4.3 Medelis, Inc. Oncology Clinical Trial Introduction
11.4.4 Medelis, Inc. Revenue in Oncology Clinical Trial Business (2016-2021)
11.4.5 Medelis, Inc. Recent Development
11.5 Medpace Holdings, Inc.
11.5.1 Medpace Holdings, Inc. Company Details
11.5.2 Medpace Holdings, Inc. Business Overview
11.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Introduction
11.5.4 Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2016-2021)
11.5.5 Medpace Holdings, Inc. Recent Development
11.6 PAREXEL International
11.6.1 PAREXEL International Company Details
11.6.2 PAREXEL International Business Overview
11.6.3 PAREXEL International Oncology Clinical Trial Introduction
11.6.4 PAREXEL International Revenue in Oncology Clinical Trial Business (2016-2021)
11.6.5 PAREXEL International Recent Development
11.7 Pharmaceutical Product Development, LLC
11.7.1 Pharmaceutical Product Development, LLC Company Details
11.7.2 Pharmaceutical Product Development, LLC Business Overview
11.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Introduction
11.7.4 Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2016-2021)
11.7.5 Pharmaceutical Product Development, LLC Recent Development
11.8 Pivotal
11.8.1 Pivotal Company Details
11.8.2 Pivotal Business Overview
11.8.3 Pivotal Oncology Clinical Trial Introduction
11.8.4 Pivotal Revenue in Oncology Clinical Trial Business (2016-2021)
11.8.5 Pivotal Recent Development
11.9 PRA Health Sciences
11.9.1 PRA Health Sciences Company Details
11.9.2 PRA Health Sciences Business Overview
11.9.3 PRA Health Sciences Oncology Clinical Trial Introduction
11.9.4 PRA Health Sciences Revenue in Oncology Clinical Trial Business (2016-2021)
11.9.5 PRA Health Sciences Recent Development
11.10 Syneos Health
11.10.1 Syneos Health Company Details
11.10.2 Syneos Health Business Overview
11.10.3 Syneos Health Oncology Clinical Trial Introduction
11.10.4 Syneos Health Revenue in Oncology Clinical Trial Business (2016-2021)
11.10.5 Syneos Health Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 腫瘍臨床試験の世界市場規模・現状・予測2021年-2027年(Global Oncology Clinical Trial Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。